Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
704
-
Total 13F shares, excl. options
-
90.8M
-
Shares change
-
-1.11M
-
Total reported value, excl. options
-
$33.5B
-
Value change
-
-$492M
-
Put/Call ratio
-
1.3
-
Number of buys
-
357
-
Number of sells
-
-336
-
Price
-
$369.72
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2020
861 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2020.
DEXCOM INC - Common Stock (DXCM) has 704 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.8M shares
of 392M outstanding shares and own 23.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.2M shares), BlackRock Inc. (7.01M shares), FMR LLC (6.98M shares), BAILLIE GIFFORD & CO (5.45M shares), STATE STREET CORP (3.86M shares), MORGAN STANLEY (3.11M shares), JPMORGAN CHASE & CO (3.06M shares), SANDS CAPITAL MANAGEMENT, LLC (2.29M shares), LONE PINE CAPITAL LLC (2.27M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2.14M shares).
This table shows the top 704 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.